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Background. Among adolescents and young adults with DSM-IV alcohol use disorders (AUDs), there are inter-
individual diﬀerences in the speed of transition from initial alcohol use (AU) to AUD. AUDs are highly co-morbid
with other mental disorders. The factors associated with rapid transition from ﬁrst AU to AUD remain unknown and
the role of mental disorders in rapid transitions is unclear. Given this background we examined (1) whether prior
anxiety, mood, externalizing and non-alcohol substance use disorders are related to the risk and speed of transition
from ﬁrst AU to DSM-IV alcohol abuse (AA) and alcohol dependence (AD) and (2) whether early age of onset of
prior mental disorders (PMDs) is a promoter of rapid transition.
Method. A total of 3021 community subjects (97.7% lifetime AU) aged 14–24 years at baseline were followed up
prospectively for up to 10 years. AU and mental disorders were assessed with the DSM-IV/M-CIDI.
Results. Among subjects with lifetime AU, several PMDs, such as speciﬁc phobia, bipolar disorder and nicotine
dependence, were associated with an increased risk of AUD independent of externalizing disorders. Associations of
PMDs with the speed of transition to AUDs were mostly weak and inconsistent. Only social phobia and externalizing
disorders were associated with faster transitions to AD even after adjustment for other PMDs. Earlier age of onset of
PMD was not associated with rapid transition.
Conclusions. Mental disorders are associated with the risk of AUD. With the possible exception of social phobia and
externalizing disorders, they do not promote rapid transition, even if they occur particularly early. Future research
needs to identify factors relevant to rapid transition to AUD.
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Introduction
In this study we investigated whether DSM-IV
anxiety, mood, non-alcohol substance use disorders
(DSM-IV abuse and dependence) and externalizing
disorders that occur prior to DSM-IV alcohol use dis-
orders (AUDs) are associated with an increased risk
and speed of transition from ﬁrst alcohol use (AU) to
DSM-IV alcohol abuse (AA) and alcohol dependence
(AD) in adolescence and young adulthood. In this
regard, we also examined the role of early onset of
prior mental disorders (PMDs) and gender.
AU is associated with the risk of serious conse-
quences such as cardiovascular disease, unintentional
injuries (Rehm et al. 2006) and AUDs. AUDs
(especially AD) are disabling mental disorders (Hasin
et al. 2007) and may occur as early as in adolescence
and young adulthood (Bonomo et al. 2004 ; Grant et al.
2004a ; Nelson & Wittchen, 1998). AD with onset in
adolescence is especially malignant (Hingson et al.
2006). AUDs are highly co-morbid with mood,
anxiety, externalizing and other substance use dis-
orders. Co-morbidity is more frequent in younger
adults (Burns & Teesson, 2002 ; Kendler et al. 2003 ;
Grant et al. 2004b ; Hasin et al. 2007).
Mental disorders and their symptoms are risk fac-
tors for AUDs and problematic AU (Kushner et al.
1999 ; Crum & Pratt, 2001; Zimmermann et al. 2003 ;
Goodwin et al. 2004 ; Haynes et al. 2005). For example,
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social phobia and pronounced depressive symptoms
predicted AD (Gilman & Abraham, 2001; Crum et al.
2008a ; Buckner & Turner, 2009). Externalizing dis-
orders are well-documented risk factors for AUDs
(Elkins et al. 2007). However, few studies on this topic
fulﬁll all of the following criteria : inclusion of young
adolescents, a long follow-up interval and a wide
range of DSM-IV diagnoses considered as predictors
and control variables (Buckner et al. 2008a). Therefore,
we investigate various DSM-IV PMDs as risk factors
for DSM-IV AUDs with thorough adjustment for co-
variates in a 10-year prospective epidemiological
study including young adolescents.
We hypothesized that an excess risk of AUD exists
for especially early PMD onset. Earlier PMDs show
greater severity and co-morbidity, poorer health out-
comes and problematic coping styles (Beesdo et al.
2007 ; Keenan-Miller et al. 2007 ; Hammen et al. 2008 ;
Sansone & Sansone, 2009). Early-onset PMDs predict
problematic substance use behaviors that are related
to AUDs (DeWit et al. 2000 ; Bonomo et al. 2004; Crum
et al. 2008b ; Sihvola et al. 2008). Major depression and
social phobia also occurred earlier in subjects with
secondary AUD than in subjects without AUD (Grant
et al. 1996 ; Buckner et al. 2008b).
It is also of interest to determine whether PMDs
play a role in the speed of transition to AUDs. The
substance-speciﬁc latency between ﬁrst use and onset
of a substance use disorder is longer for alcohol than
for cannabis and cocaine (Wagner & Anthony, 2002 ;
Behrendt et al. 2009). It can span more than 10 years
(DeWit et al. 2000) with considerable inter-individual
variation. Some adolescents develop an AUD in the
ﬁrst 2 years after ﬁrst AU (Wittchen et al. 2008).
Information on the promoters of such rapid transitions
would improve the understanding of individual dif-
ferences in AUD development and help to identify
subjects who need timely interventions (Wittchen et al.
2008) and have poorer AD prognoses (Hingson et al.
2006). However, factors characterizing these subjects
remain understudied. Because of lower self-eﬃcacy
(John et al. 2004), higher impulsivity (Kliegel et al.
2006), and instrumental AU (Thomas et al. 2003) in
mental disorders, PMDs may lead to reduced control
over AU. Therefore, we hypothesized that any and
early PMDs are associated with faster transitions to
AUDs.
Although gender diﬀerences in AUDs (Grant et al.
2004a), mood, anxiety and externalizing disorders
(Blazer et al. 1994 ; Wittchen et al. 1998b ; Kendler et al.
2003 ; Wilhelm et al. 2003) are well documented, the
role of gender in the relationship between PMD and
the speed of transition to AUD remains unclear.
Female gender has been linked with faster transitions
to alcohol problems (Randall et al. 1999), but more
recent studies found no or little evidence for a faster
AUD development in women (Wagner & Anthony,
2007 ; Wittchen et al. 2008). We hypothesized that there
are no gender diﬀerences in the speed of transition to
AUD.
Given this background we examined whether
(1) PMDs are associated with a higher risk of AUDs
and a higher speed of transition from ﬁrst AU to AUD,
(2) associations with speed of transition diﬀer by
gender and (3) early PMD onset is associated with the
risk and speed of transition.
Method
Study sample and design
The Early Developmental Stages of Psychopathology
(EDSP) study is a prospective longitudinal community
study on the prevalence, course, vulnerabilities and
risk factors of substance use and substance use dis-
orders in adolescence and early adulthood. The study
includes a baseline (T0 ; conducted in 1995) and three
follow-up assessments (T1, T2, T3) (Wittchen et al.
1998c ; Lieb et al. 2000 ; Beesdo et al. 2010).
The study sample consisted of 3021 German-
speaking subjects (1533 males, 1488 females) aged 14–
24 years at baseline. The sample was drawn randomly
from government registries in metropolitan Munich,
Germany. As the study focused on early develop-
mental stages of psychopathology, individuals aged
14–15 years were sampled at twice the probability of
those aged 16–21 years, who were sampled at twice
the probability of those aged 22–24 years. The follow-
up examinations were carried out approximately 1.6
years (T1, median interval since baseline), 3.5 years
(T2) and 8.2 years (T3) later. At T1, only the younger
cohort of subjects aged 14–17 years at baseline was
assessed (n=1228). Response rates were 70.9% at T0
(n=3021), 84.3% (n=2548) at T2 and 73.2% (n=2210)
at T3. At T3, the age range was 21–34 years. Further
detailed information on the study can be found else-
where (Wittchen et al. 1998c ; Lieb et al. 2000).
Participants were asked whether they were willing
to answer questions on illegal substances truthfully
(commitment probe). A total of 142 subjects who de-
clined at one or more waves were excluded from all
analyses with variables concerning illegal substances.
Any AU, regular AU (at least weekly) or hazardous
AU (o20 g of ethanol for women oro40 g of ethanol
for men almost every day) at T0 did not predict drop-
out at any follow-up, with one exception : in the
younger cohort, regular AU at T0 predicted drop-out
at the ﬁrst but not at any other follow-up (if subjects
did not participate in T1, the T0–T2 interval was
covered in the T2 assessment).
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The cumulative incidence rate up to T3 was 97.7%
for AU (n=2929), 24.7% for AA (n=741) and 11.0%
for AD (n=327).
Diagnostic assessment
At all assessment waves, participants were inter-
viewed face to face with the computer-assisted, fully
standardized Munich-Composite International
Diagnostic Interview (DIA-X/M-CIDI ; Wittchen &
Pﬁster, 1997 ; Wittchen et al. 1998a), an updated ver-
sion of the World Health Organization (WHO) CIDI
(Wittchen & Semmler, 1990). The lifetime version was
used at baseline ; a follow-up interval version was
used at the subsequent waves. With the DIA-X/M-
CIDI it is possible to assess symptoms, syndromes and
diagnoses of 48 mental disorders, along with infor-
mation about onset, severity and impairment. For the
diagnoses presented here, the computerized M-CIDI/
DSM-IV algorithms were applied. The DIA-X/M-CIDI
is supplemented by a respondent’s booklet including
symptom lists and cognitive aids to help the respon-
dent with answering symptom questions. The test–
retest reliability and validity of the DIA-X/M-CIDI
diagnoses have been established (Lachner et al. 1998 ;
Reed et al. 1998 ; Wittchen et al. 1998a). Interviewers,
most of whom were clinical psychologists, received
intensive training on the DIA-X/M-CIDI, followed by
monitored practice interviews at baseline and booster
sessions before each subsequent wave. Further infor-
mation has been provided elsewhere (Wittchen et al.
1998c ; Lieb et al. 2000).
Assessment of AU and AUD
AU and AUD were assessed with the DIA-X/M-CIDI
section on AU, which begins with questions on quan-
tity, frequency, age of onset and age of recency of use.
For the assessment of diagnostic criteria, at least
minimal AU was required; deﬁned as (1) AU at least
three times a week, or more than three ‘standard
drinks ’ per drinking day, in subjects who had drunk
on more than 12 occasions in at least 1 year of their
lives (applied for AD) or (2) AU on at least 13 oc-
casions in a 12-month period (for AA). AD was also
assessed in subjects who met the minimal AU criteria
in shorter periods. The following AU levels were con-
sidered here : any use, DSM-IV dependence and DSM-
IV abuse (non-hierarchical).
Statistical analysis
To account for diﬀerent sampling probabilities at
baseline according to age, and response rates at base-
line varying over age, gender and geographic region,
data were weighted. The Stata Software package
version 11.0 (StataCorp, 2009) was used for all calcu-
lations and to compute robust variances, conﬁdence
intervals (CIs) and p values (by applying the Huber–
White sandwich matrix) required when basing
analyses on weighted data (Royall, 1986). Cumulative
lifetime incidence was generated using the last
observation carried forward (LOCF) method, that is
the information obtained until the last available as-
sessment was taken into account. This enabled us to
use information from subjects who had dropped out of
the study during the assessments. According to CIDI
conventions, age of AUD onset was deﬁned as age at
ﬁrst AUD symptom.
The Kaplan–Meier (Therneau & Grambsch, 2000)
estimator was used to estimate the age-dependent
cumulative lifetime incidence of AU and mental dis-
orders. Cox regressions were applied for assessing
overall diﬀerences in risk of transition from ﬁrst AU to
AUD over time (time scale=years from ﬁrst AU to
AUD) across PMD status. Covariates (factors of inter-
est and control variables) were entered into the Cox
regression analysis as time-dependent covariates to
ensure that PMD had occurred prior to AUD [age of
onset of PMD <t, t=1, 2, …, minimum (age of onset
AUD – age of onset AU, age at last assessment – age of
onset AU)]. In the Cox regression, cases with AU and
AUD onset within the same 12-month period (i.e.
length of transition=0 years) are excluded automati-
cally in Stata (StataCorp, 2009). To prevent this, we
shifted the time scale by 1 year upwards, by replacing
0 years by 1 year, 1 year by 2 years, and so on.
Diﬀerent curves according to birth cohort and gen-
der were allowed for by ﬁtting stratiﬁed Cox regres-
sions (Therneau & Grambsch, 2000). Schoenfeld
residuals were used to test whether group diﬀerences
varied over time (Therneau & Grambsch, 2000). When
necessary, the interaction term covariaternumber of
years since AU was added to the model, to improve
the model ﬁt and to assess how strongly the hazard
ratios (HRs) varied over time. Here, the model-based
time-dependent HR is given by: HR(t)=HR (main ef-
fect of covariate)rHR (interaction eﬀect of covariate)t,
where t is the number of years since onset of AU.
For the Cox regression analysis, we used data from
subjects with lifetime AU (n=2929). Few subjects had
reported AU, AUD or mental disorders other than
AUD, but had not provided the respective age of onset
information. Data from these subjects were excluded
from the survival analyses1.# To assess whether early
PMD onset was associated with a higher speed of
transition to AUD we used the dimensional age of
onset of the respective PMD, that is we determined
# The notes appear after the main text.
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Table 1. Sequence of alcohol use, DSM-IV alcohol use disorders (AUDs) and co-morbid mental disorders (T0–T3 ; n=3021)a
Onset of diagnosis in relation to alcohol use (AU),
alcohol abuse or alcohol dependence (AD)
TotalPrimary Same year Secondary
nag %wb n %wc n %wc n %wc nf
Occurring alcohol use
Any aﬀective disorderi 885 98.59 169 17.88 63 5.94 636 76.18 868
Major depression 623 98.67 82 12.77 36 4.88 493 82.35 611
Dysthymia 148 98.39 38 23.38 8 5.36 98 71.25 144
Bipolar disorder (I or II) 123 97.09 32 24.12 16 11.37 73 64.51 121
Any anxiety disorderi 951 97.66 598 64.18 49 4.95 248 30.87 895
Speciﬁc phobia 498 97.69 374 77.31 19 3.98 75 18.71 468
Social phobia 209 94.40 105 53.27 19 8.68 71 38.04 195
Panic attacks 283 99.42 55 17.98 18 6.77 203 75.25 276
Somatoform disorders 1055 98.12 477 44.52 91 8.83 460 46.65 1028
Any substance use disorderi 984 99.81 34 3.11 64 6.28 837 90.61 935
Nicotine dependence 847 99.94 35 3.58 61 6.63 741 89.79 837
Cannabis abusede 304 99.51 6 1.44 9 2.04 286 96.52 301
Externalizing disorderh 360 98.52 189 53.59 59 16.98 107 29.42 355
Co-morbid alcohol abusee
Any aﬀective disorderi 885 28.12* 131 50.16 27 9.83 104 40.01 262
Major depression 623 25.98* 65 38.31 15 9.17 88 52.52 168
Dysthymia 148 31.07* 24 47.78 5 11.14 16 41.07 45
Bipolar disorder (I or II) 123 38.47* 31 59.55 7 13.09 14 27.36 52
Any anxiety disorderi 951 25.27* 188 80.71 7 2.62 38 16.66 233
Speciﬁc phobia 498 24.48* 106 92.68 2 1.24 6 6.07 114
Social phobia 209 31.19* 49 74.42 1 2.85 13 22.73 63
Panic attacks 283 32.96* 35 40.15 9 8.84 47 51.01 91
Somatoform disorders 1055 23.67* 177 67.61 21 8.10 54 24.29 252
Any substance use disorderi 984 41.40* 119 30.72 85 19.21 193 50.07 397
Nicotine dependence 847 38.66* 106 32.02 70 18.92 155 49.06 331
Cannabis abusede 304 64.17* 30 15.87 30 15.03 187 69.10 187
Externalizing disorderh 360 54.78* 191 96.06 8 2.92 2 1.03 201
Co-morbid alcohol dependence
Any aﬀective disorderi 885 14.48* 83 60.27 15 12.01 39 27.72 137
Major depression 623 12.99* 40 46.74 11 11.18 36 42.08 87
Dysthymia 148 19.83* 18 56.55 3 10.44 9 33.01 30
Bipolar disorder (I or II) 123 23.56* 20 69.30 1 3.19 9 27.52 30
Any anxiety disorderi 951 14.11* 115 85.87 3 3.09 14 11.04 132
Speciﬁc phobia 498 14.96* 68 90.55 1 4.34 4 5.11 73
Social phobia 209 18.74* 27 64.56 2 7.16 10 28.28 39
Panic attacks 283 19.72* 23 39.51 8 14.94 22 45.55 53
Somatoform disorders 1055 11.54* 86 63.97 10 7.79 27 28.24 123
Any substance use disorderi 984 23.52* 97 42.79 46 21.98 68 35.22 211
Nicotine dependence 847 22.95* 87 45.31 40 21.80 56 32.98 183
Cannabis abusede 304 37.01* 26 24.68 16 12.97 55 62.34 97
Externalizing disorderh 360 28.90* 93 91.49 7 8.51 0 0.00 100
a Based on cumulative incidence ; T0–T3 ; n=3021.
bWeighted percentage of AU and AUD among subjects with the respective mental disorder.
cWeighted row percentages.
d n=142 excluded (unwilling to answer drug questions truthfully).
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whether higher (compared to lower) age of onset was
associated with the speed of transition. Subjects with
PMD onset after or in the same year as AUD onset
were excluded from this analysis.
First, the Cox regression analysis was conducted
with adjustment for age and gender (model I). In
model II, we additionally adjusted for other PMDs: if
the covariate of interest was a mood disorder, we ad-
justed for any anxiety disorder and non-alcohol sub-
stance use disorders (nicotine dependence, cannabis
abuse or dependence, abuse or dependence of illegal
drugs other than cannabis). If the covariate of interest
was an anxiety disorder, we adjusted for any mood
disorder and non-alcohol substance use disorders.
When the covariate of interest was a non-alcohol sub-
stance use disorder, we adjusted for all other non-
alcohol substance use disorders, any anxiety and any
mood disorder. With externalizing disorders as cov-
ariate, we adjusted for any mood, any anxiety and all
non-alcohol substance use disorders. For anxiety dis-
orders that were signiﬁcant predictors in model II, we
repeated model II with additional adjustment (model
IIA) for selected other anxiety disorders (other anxiety
disorders were selected as covariates only if they were
signiﬁcant predictors in model II) and for a category of
those anxiety disorders that are otherwise not con-
sidered as covariates here because of insuﬃcient
power (see next section). In model III, we repeated
model II with additional adjustment for externalizing
disorders. Statistical power did not permit diﬀeren-
tiation between substance use disorders related to
illegal drugs other than cannabis.
Covariates
Covariates (PMDs) were calculated from their cumu-
lative lifetime status and the respective age of onset
variable for : any mood, any anxiety and any non-
alcohol substance use disorder2, major depression,
dysthymia, bipolar disorder (bipolar I and bipolar II
disorder), speciﬁc phobia, social phobia, nicotine
dependence, cannabis abuse (non-hierarchical) and
somatoform disorders (any DSM-IV somatoform
disorder or somatoform/dissociative syndrome in-
cluding SSI 4/6). For phobias, impairment was as-
sessed but only requested for DSM-IV diagnosis
after age 17 because of the possibly limited reliability
of impairment reports in young respondents and
because these disorders occur particularly early
(Wittchen et al. 1999a, b). DSM-IV panic attacks were
considered and are subsequently listed among the
anxiety disorders but not included in the any anxiety
disorder variable. Diagnosis of externalizing disorders
(conduct or antisocial personality disorder) was ob-
tained from parental reports on conduct disorder at T1
and participants ’ reports on both disorders at T2 re-
sulting in information on 2638 subjects. Age of onset of
antisocial personality disorder was set to age 13 by
convention3.
Results
Co-morbidity and temporal sequence
Table 1 shows that rates of lifetime AU in subjects with
lifetime mental disorders were comparable to those in
the entire sample. The risk of lifetime AUD was elev-
ated for all considered lifetime disorders (all p values
<0.05). In the case of lifetime co-morbidity, onset of
speciﬁc mental disorders occurred prior to AU in over
50% of subjects with speciﬁc phobia, social phobia and
externalizing disorders, but secondary to AU for 64.5–
96.5% of cases of all other mental disorders except
somatoform disorders. Other mental disorders mainly
occurred primary to AA (except major depression,
dysthymia, panic attacks and substance use disorders)
and to AD (except substance use disorders, major de-
pression and panic attacks).
PMD and the risk and speed of transition to AUD
Model I : adjusted for age and gender. Table 2 shows that
all mood and anxiety disorders, cannabis abuse, nic-
otine dependence, somatoform and externalizing dis-
orders were associated with a higher risk for AA and
(Table 1 footnote continued)
e Hierarchy rule not applied.
f Number of co-morbid cases ; only cases who provided age of onset information were considered.
g Total number of cases with the respective diagnosis in the sample (irrespective of alcohol use or alcohol use disorder).
h Either conduct disorder or antisocial personality disorder ; based on information from 2638 subjects at T1 and T2.
i Any anxiety disorder : panic disorder, agoraphobia without history of panic disorder, generalized anxiety disorder,
obsessive–compulsive disorder (OCD), post-traumatic stress disorder (PTSD), speciﬁc and social phobia ; any mood disorder :
major depression, dysthymia, bipolar disorder I or II ; any non-alcohol substance use disorder : nicotine dependence or any
illegal substance use disorder.
* Higher risk of lifetime alcohol abuse or dependence (odds ratio adjusted for gender and age at last observation signiﬁcant
with p<0.05 ; table with odds ratios and 95% conﬁdence intervals available upon request).
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Table 2. The risk of DSM-IV alcohol abuse and dependence by prior mental disorders (PMDs) : overall diﬀerence in models I–IIIa
Alcohol abuse (AA) Alcohol dependence (AD)
HR 95% CI p
Probability>x2
(p value)b HR 95% CI p
Probability>x2
(p value)b
Model Ia
Any aﬀective disorderg 1.67 1.3–2.0 <0.001 0.08 2.74 2.0–3.6 <0.001 0.30
Major depression 1.33 1.05–1.7 0.016 0.48 1.93 1.3–2.7 <0.001 0.43
Dysthymia 1.75 1.2–2.5 0.002 0.58 N.A.c
Bipolar disorder 2.03 1.3–3.0 <0.001 0.19 2.99 1.8–4.9 <0.001 0.58
Any anxiety disorderg 1.44 1.2–1.7 <0.001 0.89 2.44 1.9–3.1 <0.001 0.91
Speciﬁc phobia 1.38 1.1–1.7 0.005 0.81 2.40 1.7–3.3 <0.001 0.59
Social phobia 1.74 1.2–2.4 <0.001 0.32 2.31 1.5–3.4 <0.001 0.13
Panic attacks 1.80 1.3–2.4 <0.001 0.62 2.69 1.8–4.0 <0.001 0.22
Somatoform disorders 1.41 1.1–1.7 <0.001 0.74 1.53 1.1–2.0 0.003 0.30
Any substance use disorderg 2.19 1.8–2.6 <0.001 0.58 4.20 3.2–5.5 <0.001 0.21
Nicotine dependence 1.94 1.6–2.3 <0.001 0.18 4.11 3.1–5.4 <0.001 0.28
Cannabis abusede 2.72 2.0–3.7 <0.001 0.56 2.66 1.8–3.9 <0.001 0.98
Externalizing disorderf 2.46 2.0–3.0 <0.001 0.92 3.02 2.2–4.0 <0.001 0.00
Model IIad
Any aﬀective disorderg 1.39 1.1–1.7 0.001 0.32 1.75 1.2–2.4 0.001 0.37
Major depression 1.12 0.8–1.4 0.324 0.86 1.27 0.8–1.8 0.197 0.51
Dysthymia 1.29 0.8–1.9 0.181 0.54 N.A.c
Bipolar disorder 1.76 1.1–2.6 0.004 0.30 1.84 1.1–3.0 0.013 0.27
Any anxiety disorderg 1.22 1.01–1.5 0.039 0.85 1.96 1.4–2.6 <0.001 0.38
Speciﬁc phobia 1.21 0.9–1.5 0.106 0.67 1.93 1.3–2.7 <0.001 0.68
Social phobia 1.39 1.00–1.9 0.044 0.43 1.74 1.1–2.6 0.006 0.24
Panic attacks 1.44 1.05–2.0 0.023 0.78 1.55 1.02–2.3 0.036 0.22
Somatoform disorders 1.18 0.9–1.4 0.091 0.38 1.10 0.8–1.5 0.505 0.16
Any substance use disorderg 2.02 1.6–2.4 <0.001 0.75 3.50 2.6–4.6 <0.001 0.30
Nicotine dependence 1.58 1.2–1.9 <0.001 0.35 2.96 2.1–4.0 <0.001 0.37
Cannabis abusede 2.20 1.6–3.0 <0.001 0.80 1.37 0.9–2.1 0.130 0.60
Externalizing disorderf 2.11 1.7–2.6 <0.001 0.82 2.19 1.6–3.0 <0.001 0.01
Model IIAa
Speciﬁc phobia 1.85 1.3–2.6 <0.001 0.50
Social phobia 1.33 0.9–1.9 0.083 0.32 1.41 0.9–2.2 0.116 0.36
Panic attacks 1.38 0.9–2.0 0.080 0.98 1.11 0.6–1.9 0.694 0.43
Model IIIad
Any aﬀective disorderg 1.41 1.1–1.7 0.001 0.93 1.78 1.2–2.5 0.001 0.81
Major depression 1.17 0.9–1.5 0.208 0.55 1.29 0.8–2.0 0.226 0.36
Dysthymia 1.35 0.8–2.1 0.164 0.38 N.A.c
Bipolar disorder 1.67 1.1–2.4 0.007 0.76 2.04 1.2–3.3 0.003 0.14
Any anxiety disorderg 1.07 0.8–1.3 0.472 0.46 1.59 1.1–2.2 0.003 0.72
Speciﬁc phobia 1.07 0.8–1.4 0.574 0.29 1.62 1.1–2.3 0.007 0.73
Social phobia 1.26 0.8–1.8 0.187 0.52 1.39 0.8–2.2 0.155 0.09
Panic attacks 1.34 0.9–1.9 0.084 0.93 1.35 0.8–2.1 0.158 0.40
Somatoform disorders 1.14 0.9–1.4 0.210 0.56 1.13 0.8–1.5 0.414 0.49
Any substance use disorderg 1.64 1.3–2.0 <0.001 0.52 2.95 2.1–4.1 <0.001 0.96
Nicotine dependence 1.36 1.09–1.7 0.006 0.56 2.62 1.8–3.7 <0.001 0.65
Cannabis abusede 1.80 1.2–2.6 0.001 0.60 1.10 0.6–1.8 0.681 0.61
HR, Hazard ratio ; CI, conﬁdence interval ; N.A., not applicable.
aModel I : adjusted for gender and age at last observation. Model II : additionally adjusted for substance use disorders
(nicotine dependence, cannabis abuse or dependence, abuse or dependence of illegal drugs other than cannabis), any anxiety
disorder (not if the covariate of interest was an anxiety disorder), and any mood disorder (not if the covariate of interest was a
mood disorder). When the covariate of interest was a substance use disorder, the speciﬁc analysis was not adjusted for this
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AD (comparison group in models I–III were subjects
without the respective PMD). Two signiﬁcant interac-
tions with time (not shown in Table 2) were found:
social phobia was associated with a lower speed of
transition to AD (main eﬀect HR 1.19, interaction eﬀect
HR 1.14, 95% CI 1.02–1.27, p=0.019). Externalizing
disorders were associated with a higher speed of
transition to AD (main eﬀect HR 4.69, interaction eﬀect
HR 0.89, 95% CI 0.82–0.98, p=0.018).
Model II : additional adjustment for other PMD. Bipolar
disorder, social phobia, panic attacks, nicotine depen-
dence, cannabis abuse and externalizing disorders
were associated with a higher risk of AA. AD was
predicted by bipolar disorder, speciﬁc phobia, social
phobia, panic attacks, nicotine dependence and ex-
ternalizing disorders. Surprisingly, in model II, social
phobia was associated with a higher speed of tran-
sition to AD (main eﬀect HR 0.95, interaction eﬀect HR
1.12, 95% CI 1.008–1.26, p=0.035), as were externaliz-
ing disorders (main eﬀect HR 3.25, interaction eﬀect
HR 0.90, 95% CI 0.83–0.98, p=0.027).
Model IIA: adjustment for selected anxiety disorders. In
this model, all associations were adjusted for rare
anxiety disorders and for those particular anxiety
disorders that were signiﬁcant predictors in model II.
Social phobia did not predict AA (additional covari-
ate : panic attacks). Panic attacks did not predict AA
(additional covariate : social phobia). Speciﬁc phobia
predicted AD (additional covariates : social phobia,
panic attacks). Social phobia was not associated with
the risk but with a higher speed of transition to AD
(main eﬀect HR 0.79, interaction eﬀect HR 1.12, 95% CI
1.002–1.26, p=0.045; additional covariates : speciﬁc
phobia, panic attacks). Panic attacks did not predict
AD (additional covariates : speciﬁc and social phobia).
Model III : additional adjustment for externalizing dis-
orders. In this model, bipolar disorder, cannabis abuse
and nicotine dependence were associated with a
higher risk of AA. AD was predicted by bipolar dis-
order, speciﬁc phobia and nicotine dependence. Social
phobia was associated with a higher speed of tran-
sition to AD (main eﬀect HR 0.69, interaction eﬀect HR
1.14, 95% CI 1.009–1.30, p=0.036).
Gender diﬀerences
To assess whether associations between PMD and the
speed of transition to AUD diﬀered by gender, we
added the interaction term PMDrgenderrtime to the
model. The only signiﬁcant interaction was found for
dysthymiargenderrtime (AA as outcome, p=0.015).
In the male and female subgroups, the results on the
association between dysthymiartime and AA in-
dicated a trend towards a faster transition to AA in
women with dysthymia (main eﬀect HR 2.19, interac-
tion eﬀect HR 0.84, 95% CI 0.70–1.02, p=0.093) and a
trend towards a slower transition to AA in men (main
eﬀect HR 1.91, interaction eﬀect HR 1.05, 95% CI 0.92–
1.18, p=0.424), but the results were not signiﬁcant.
Earlier PMD onset
Earlier age of onset of major depression, dysthymia,
speciﬁc phobia and cannabis abuse was associated
with a higher risk of AA. In model II, this was found
for major depression and cannabis abuse. Table 3
shows that earlier onset of major depression, speciﬁc
phobia and nicotine dependence was associated with a
higher risk of AD in both models.
In model I, later age of onset of panic attacks was
marginally associated with a faster transition to AA
(main eﬀect HR 0.73, interaction eﬀect HR 1.07, 95% CI
1.01–1.13, p=0.011) and AD (main eﬀect HR 0.63,
particular, but for all other substance use disorders. When the covariate of interest was an externalizing disorder, the analysis
was adjusted for any mood, any anxiety and all non-alcohol substance use disorders. Model IIA : as model II but with
additional adjustment for anxiety disorders that predicted the respective alcohol use disorder (AUD) in model II and for an
aggregated variable including generalized anxiety disorder, obsessive–compulsive disorder (OCD), post-traumatic stress
disorder (PTSD), agoraphobia without history of panic disorder and panic disorder. Model III : as model II with additional
adjustment for externalizing disorders.
b Schoenfeld Residual Test with p<0.05 indicates that HRs depend on time.
c Not applicable because of insuﬃcient statistical power.
d n=142 excluded (unwilling to answer drug questions truthfully).
e Hierarchy rule not applied.
f Either conduct disorder or antisocial personality disorder ; information available from T1 and T2 (n=2638).
g Any anxiety disorder : panic disorder, agoraphobia without history of panic disorder, generalized anxiety disorder, OCD,
PTSD, speciﬁc and social phobia ; any mood disorder : major depression, dysthymia, bipolar disorder I or II ; any non-alcohol
substance use disorder : nicotine dependence or any illegal substance use disorder.
(Table 2 footnote continued)
Mental disorders and transitions to alcohol use disorders 1079
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291710001418
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 17:01:10, subject to the Cambridge Core terms of use, available at
interaction eﬀect HR 1.06, 95% CI 1.006–1.12,
p=0.029). Because of insuﬃcient statistical power,
these associations could not be investigated in model
II. After adjustment for covariates, later age of onset of
cannabis abuse was associated with a faster transition
to AA (main eﬀect HR 0.05, interaction eﬀect HR 1.76,
95% CI 1.17–2.66, p=0.007). No other signiﬁcant as-
sociation with speed was found (the results on the in-
teraction with time are available upon request).
Externalizing disorders were not considered here be-
cause of lacking variance in age of onset (see
Covariates section).
Table 3. Earlier onseta of a prior mental disorder (PMD) and the risk of transition to DSM-IV alcohol use disorders (AUDs)
Alcohol abuse Alcohol dependence
HR 95% CI p
Probability
>x2 (p value)b HR 95% CI p
Probability
>x2 (p value)b
Model Ie
Any aﬀective disorderg 0.97 0.9–1.0 0.384 0.79 0.91 0.8–0.9 0.001 0.91
Major depression 0.82 0.7–0.9 <0.001 0.63 0.83 0.7–0.9 0.001 0.87
Dysthymia 0.67 0.5–0.8 <0.001 0.85 N.A.d
Bipolar disorder 1.16 0.9–1.4 0.108 0.70 N.A.d
Any anxiety disorderg 0.97 0.9–1.0 0.161 0.67 0.96 0.9–1.0 0.164 0.82
Speciﬁc phobia 0.90 0.8–0.9 0.003 0.45 0.94 0.8–1.0 0.049 0.72
Social phobia 0.94 0.8–1.0 0.169 0.87 1.13 0.9–1.4 0.161 0.66
Panic attacks 0.93 0.8–1.0 0.143 0.69 0.85 0.7–1.0 0.074 0.51
Somatoform disorders 0.97 0.9–1.0 0.191 0.64 0.97 0.9–1.0 0.434 0.78
Any substance use disorderg 0.93 0.8–1.0 0.060 0.72 0.84 0.7–0.9 0.027 0.70
Nicotine dependence 0.94 0.8–1.0 0.154 0.67 0.78 0.6–0.9 0.006 0.83
Cannabis abusecf 0.65 0.4–0.9 0.019 0.75 0.78 0.6–1.0 0.057 0.74
Model IIce
Any aﬀective disorderg 0.97 0.9–1.0 0.360 0.78 0.92 0.8–0.9 0.008 0.94
Major depression 0.79 0.6–0.9 0.007 0.57 0.75 0.6–0.9 <0.001 0.79
Dysthymia N.A.d N.A.d
Bipolar disorder 1.23 0.9–1.6 0.081 0.50 N.A.d
Any anxiety disorderg 0.96 0.9–1.0 0.068 0.58 0.94 0.9–0.99 0.027 0.51
Speciﬁc phobia N.A.d 0.92 0.8–0.9 0.021 0.96
Social phobia 0.92 0.8–1.0 0.225 0.83 N.A.d
Panic attacks N.A.d N.A.d
Somatoform disorders 0.98 0.9–1.0 0.396 0.66 0.96 0.8–1.0 0.348 0.99
Any substance use disorderg 0.94 0.8–1.0 0.082 0.72 0.83 0.7–0.9 0.034 0.70
Nicotine dependence 0.93 0.8–1.0 0.151 0.92 0.76 0.6–0.9 0.006 0.73
Cannabis abusecf 0.59 0.3–0.9 0.040 0.32 0.75 0.5–1.0 0.093 0.57
HR, Hazard ratio ; CI, conﬁdence interval ; N.A., not applicable.
a Continuous variable ; age of onset of the respective disorder.
b Schoenfeld Residual Test with p<0.05 indicates that HRs depend on time.
c n=142 excluded (unwilling to answer drug questions truthfully).
d Not applicable because of insuﬃcient statistical power.
eModel I : adjusted for gender and age. Model II : additionally adjusted for substance use disorders (nicotine dependence,
cannabis abuse or dependence, abuse or dependence of illegal drugs other than cannabis), any anxiety disorder (not if the
covariate of interest was an anxiety disorder), and any mood disorder (not if the covariate of interest was a mood disorder).
When the covariate of interest was a substance use disorder, the speciﬁc analysis was not adjusted for this particular, but for all
other substance use disorders.
f Hierarchy rule not applied.
g Any anxiety disorder : panic disorder, agoraphobia without history of panic disorder, generalized anxiety disorder,
obsessive–compulsive disorder (OCD), post-traumatic stress disorder (PTSD), speciﬁc and social phobia ; any mood disorder :
major depression, dysthymia, bipolar disorder I or II ; any non-alcohol substance use disorder : nicotine dependence or any
illegal substance use disorder.
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Discussion
We examined, in a community sample of adolescents
and young adults, whether diﬀerent PMDs are as-
sociated with a higher risk and speed of transition to
AUDs, whether associations with speed diﬀered by
gender and whether early onset of PMD was as-
sociated with rapid transitions. The main ﬁndings are :
(1) several speciﬁc PMDs were associated with a
higher risk of AUDs, but only social phobia and ex-
ternalizing disorders were associated with a higher
speed of transition (to AD). (2) No gender diﬀerences
in associations between PMD and the speed of tran-
sition were found. (3) Early onset of several PMD was
associated with higher risk but not with the speed of
transition.
Several PMDs predicted AUDs. Bipolar disorders
predicted AUDs after adjustment for covariates. This
adds to cross-sectional evidence on the co-morbidity
of bipolar disorder/mania and AD (Burns & Teesson,
2002 ; Grant et al. 2004b) by showing that bipolar dis-
orders are risk factors for AUD in adolescence and
young adulthood. In accordance with the study by
Buckner et al. (2008a), we found no association be-
tween major depression and AD after adjustment for
anxiety and other disorders. A mediational relation-
ship may exist between anxiety disorders, major de-
pression and AUDs (Buckner et al. 2008a), as anxiety
disorders typically occur earlier than mood disorders
and predict these (Bittner et al. 2004 ; Kessler et al. 2005 ;
Beesdo et al. 2010).
Non-alcohol substance use disorders were consist-
ently associated with the risk of AUDs, even after ad-
justment for externalizing disorders. Externalizing
disorders are important risk factors for substance use
disorders and the existence of a shared vulnerability
has been suggested (Krueger, 1999 ; Sung et al. 2004 ;
McGue & Iacono, 2008). Our results suggest that once
a substance use disorder has occurred, it may con-
tribute to the development of AUDs independent of
externalizing disorders. It is of concern that nicotine
dependence, which predicted AUD, is highly preva-
lent (cumulative incidence rate 28.5%; Wittchen et al.
2008) in this young sample. Nicotine dependence and
cannabis abuse may be proximal risk factors for AUD.
This is indicated by the overlap of the incidence peri-
ods of these disorders (Wittchen et al. 2008) and leaves
little time for intervention before a multiple substance
use disorders status develops.
Externalizing disorders were associated with a
higher risk of AUDs and a faster transition to AD, in-
dependent of all other PMDs. This adds to the con-
sistent ﬁndings on these disorders as risk factors for
AU and AUDs (Bonomo et al. 2004 ; King et al. 2004 ;
McGue & Iacono, 2008). The impulsivity observed in
these disorders may foster a rapid development of
excessive AU.
Speciﬁc phobia was associated with the risk of AD.
Speciﬁc phobia may represent an early general vul-
nerability for anxiety, which may be related to AD
(Bru¨ckl et al. 2007 ; Stinson et al. 2007 ; Fehm et al. 2008;
Beesdo et al. 2010). However, the association was in-
dependent of other anxiety disorders and may thus be
speciﬁc. In adults, speciﬁc phobia is associated with
impaired functioning (Ramsawh et al. 2009), which
may be associated with AD. However, high case
numbers for speciﬁc phobia may have played a role
here.
Social phobia was associated with a higher risk and
speed of transition to AD even after adjustment for
covariates. This adds to the ﬁnding that social phobia
predicts AD in early adulthood independent of other
mental disorders reported at about age 16 (Buckner
et al. 2008a). Our adjustment took into account other
PMDs, including those with incidence phases that
reach into late adolescence/early adulthood, as nic-
otine and drug dependence (de Graaf et al. 2003 ;
Kessler et al. 2005 ; Wittchen et al. 2008) and panic at-
tacks that predict AUDs (Goodwin et al. 2004).
Impaired life quality and individual functioning and
the intent to relieve anxiety in social situations in so-
cial phobia (Thomas et al. 2003 ; Acarturk et al. 2008 ;
Fehm et al. 2008) may contribute to instrumental AU
and thus to the higher risk and speed of transition to
AD. In conclusion, social phobia is an important pro-
moter for AD and rapid transitions to AD in ado-
lescence and young adulthood. Thus, it may be
predictive of early-onset AD, which is particularly se-
vere (Hingson et al. 2006). Of note, these results were
found with a deﬁnition of social phobia that was less
strict for subjects under age 18. Some research in-
dicates that subthreshold social phobia is associated
with AD (Fehm et al. 2008).
The ﬁnding that several PMDs are associated with
the risk of AUD independent of other PMDs may in-
dicate the existence of diﬀerent underlying mechan-
isms such as impulsivity, self-medication by use of
anxiolytic alcohol eﬀects, and cross-sensitivity or
cross-tolerance for diﬀerent substances.
Associations with speed of transition were few.
Thus, our results conﬁrm for several PMDs that one
factor (i.e. early AU onset) is not necessarily associated
with both risk and speed of transition to AUD (DeWit
et al. 2000 ; Behrendt et al. 2009). Prerequisites of heavy
AU (e.g. availability, social acceptance) may not be
present until later adolescence (Poelen et al. 2005 ; van
Zundert et al. 2006). This may also explain the lack of
gender diﬀerences in the speed of transition in relation
to PMDs. This lack of gender diﬀerences occurs in ac-
cordance with recent studies that ﬁnd small or no
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gender diﬀerences in the speed of transition to AD
(Wagner & Anthony, 2007 ; Wittchen et al. 2008).
Nicotine dependence and cannabis use disorders
were not associated with more rapid transitions to
AUD, possibly because their main incidence phases
overlap with those of AUD (Wittchen et al. 2008).
These disorders may be proximal predictors that occur
towards the end of the transition to AUD. Subjects
with mood disorders may not experience the short-
lived alcohol eﬀects as a signiﬁcant contribution to
symptom relief, which may prevent a fast develop-
ment of instrumental drinking.
Early age of onset of PMD was associated with a
higher risk but not a higher speed of transition to
AUD. An excess risk of AUDwas found for early onset
of nicotine dependence, speciﬁc phobia and cannabis
abuse. In contrast to major depression per se, early
major depression was associated with the risk of AUD
independent of anxiety disorders. Thus, early psy-
chopathology may be a relevant distal risk factor for
AUD and warrants attention in the prevention of AUD
in adolescence/early adulthood. Our results add to
the ﬁnding that problem behaviors in childhood and
adolescence predict AU-related problems in adult-
hood (Pitka¨nen et al. 2008). The links between early
psychopathology and AUD remain to be identiﬁed.
The stability of psychopathology into adolescence may
play a role here (Dubow et al. 2008 ; Hayatbakhsh et al.
2008).
Limitations
We could not consider all PMDs of interest because of
insuﬃcient statistical power. The study covers the
high-risk phase of AUD in adolescence/early adult-
hood but does not permit conclusions concerning
AUD onset in middle/late adulthood. We used retro-
spective age-of-onset information that may underlie
recall bias.
Future research should identify factors associated
with rapid transitions to AUD and the mechanisms
linking early psychopathology with AUD. Here, in-
vestigating the role of parental AU and AUDwould be
of interest. It would be important to investigate which
characteristics of PMDs as certain symptoms or sub-
types (as of speciﬁc phobia) are related to AUDs. We
used non-hierarchical AA diagnosis in order to take
into account all AUDs that occurred over the observed
period. In future research it may be of interest to in-
vestigate cases that develop AA only.
In summary, we could show that PMDs are rarely
associated with rapid transitions to AUDs in ado-
lescence and early adulthood. However, diﬀerent
PMDs play an important role as risk factors for AUDs
in this period.
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Notes
1 Also complete information on age of onset of AU andAUD
was missing in some cases (AA: n=7, AD: n=8). In ad-
dition, several cases had reported onset of AUD as prior
to onset of AU: 21 (2.9%) for AA, six (1.9%) for AD
(percentages refer to the total number of subjects with the
respective AUD and provided age of onset information for
AU and AUD). These cases had to be excluded from the
Cox regression analysis.
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2 Any anxiety disorder : panic disorder, agoraphobia
without history of panic disorder, generalized anxiety
disorder, obsessive–compulsive disorder (OCD), post-
traumatic stress disorder (PTSD), speciﬁc and social pho-
bia ; any mood disorder : major depression, dysthymia,
bipolar disorder I or II ; any non-alcohol substance use
disorder : nicotine dependence or any illegal substance use
disorder.
3 Because of insuﬃcient statistical power, the analysis could
not be conducted for panic disorder, generalized anxiety
disorder, agoraphobia without history of panic disorder,
OCD, PTSD and cannabis dependence.
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